Valuation: Inner Mongolia Furui Medical Science Co., Ltd.

Capitalization 15.2B 2.23B 1.9B 1.76B 1.65B 3.08B 207B 3.14B 20.6B 8.06B 99.45B 8.36B 8.18B 354B P/E ratio 2026 *
51.9x
P/E ratio 2027 * 38.5x
Enterprise value 15.2B 2.23B 1.9B 1.76B 1.65B 3.08B 207B 3.14B 20.6B 8.06B 99.45B 8.36B 8.18B 354B EV / Sales 2026 *
7.8x
EV / Sales 2027 * 6.23x
Free-Float
67.03%
Yield 2026 *
1.55%
Yield 2027 * 1.6%
03-24 Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
12-17 Inner Mongolia Furui Medical plans to seek Hong Kong listing RE
12-10 Inner Mongolia Furui Medical Science ordered to rectify over information disclosure violations RE
28/10/25 Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
21/08/25 Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
21/04/25 Inner Mongolia Furui Medical Science Co., Ltd. signed equity acquisition framework agreement to acquire 96.20% stake in Chengdu Furuihui Hospital Management Co., Ltd. from Shao Yu, He Liwei, Hangzhou Ruiying Health Industry Equity Investment Fund Partnership Enterprise (L.P.) managed by Ningbo Bonded Area Yingshi Investment Management Partnership Enterprise (L.P.) and Sanya Haoyue Business Service Co., Ltd. CI
21/04/25 Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
21/04/25 Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24/10/24 Inner Mongolia Furui Medical Science Q3 Profit Down 6%; Shares Rise 6% MT
23/10/24 Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
29/08/24 Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 CI
05/07/24 Inner Mongolia Furui Medical Science Expects Up to 105% Increase in H1 Profit MT
28/04/24 Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
1 day+0.35%
1 week+2.89%
Current month-0.90%
1 month+1.38%
3 months-29.37%
6 months-16.65%
Current year-18.51%
1 week 55.45
Extreme 55.45
60.36
1 month 49.5
Extreme 49.5
60.5
Current year 49.5
Extreme 49.5
86.9
1 year 28.5
Extreme 28.5
90.68
3 years 20.34
Extreme 20.34
90.68
5 years 7.4
Extreme 7.4
90.68
10 years 6.67
Extreme 6.67
90.68
Manager TitleAgeSince
Chief Executive Officer 56 16/05/2023
Director of Finance/CFO 49 24/04/2024
Corporate Officer/Principal 62 19/05/2020
Director TitleAgeSince
Chairman 56 31/05/2005
Director/Board Member 56 19/05/2020
Director/Board Member 57 -
Change 5d. change 1-year change 3-years change Capi.($)
+0.35%+2.89%+91.84%+80.44% 2.23B
-0.09%+0.94%+19.68%-45.53% 15.54B
+1.74%+0.34%-8.32%+0.46% 1.07B
-2.12%-19.71%-47.58%-84.70% 943M
+1.37%+1.98%+2.22%-45.07% 786M
+1.12%0.00%-13.13%-46.91% 711M
+2.72%+3.15%-16.96%-52.10% 613M
+2.01%+6.48%+44.44%-37.92% 469M
+3.00%-5.85%+261.66% - 465M
+0.94%0.00%-2.33%-15.45% 389M
Average +1.10%-0.16%+33.15%-27.42% 2.32B
Weighted average by Cap. +0.24%+0.49%+24.98%-32.19%

Financials

2026 *2027 *
Net sales 1.95B 286M 243M 225M 212M 395M 26.56B 403M 2.64B 1.03B 12.76B 1.07B 1.05B 45.45B 2.44B 358M 305M 282M 265M 495M 33.26B 505M 3.31B 1.29B 15.97B 1.34B 1.31B 56.91B
Net income 280M 41.01M 34.93M 32.33M 30.44M 56.7M 3.81B 57.86M 379M 148M 1.83B 154M 151M 6.53B 394M 57.78M 49.22M 45.55M 42.89M 79.89M 5.37B 81.53M 534M 209M 2.58B 217M 212M 9.19B
Net Debt - -
Logo Inner Mongolia Furui Medical Science Co., Ltd.
Inner Mongolia Furui Medical Science Co., Ltd is a China-based company principally engaged in the diagnosis and treatment of hepatic fibrosis. The Company is mainly engaged in the manufacture and sale of medicines, the research, development and sale of diagnostic equipment, as well as the provision of related services. The Company’s main products include Fufang Biejia Ruangan talbets, Kezhi capsules and instantaneous elastic imaging equipment FibroScan. The Company distributes its products in domestic market and to overseas markets.
Employees
867
Date Price Change Volume
10/04/26 57.38 ¥ +0.35% 6,231,800
09/04/26 57.18 ¥ -1.82% 4,486,558
08/04/26 58.24 ¥ +4.34% 6,208,647
07/04/26 55.82 ¥ +0.09% 4,225,674
03/04/26 55.77 ¥ -4.31% 6,216,396
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
57.38
Average target price
-

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300049 Stock